527 | HIGH‐THROUGHPUT T CELL RECEPTOR SEQUENCING TO DETECT MEASURABLE RESIDUAL DISEASE IN SYSTEMIC T CELL LYMPHOMA TREATED WITH BRENTUXIMAB VEDOTIN: A PROSPECTIVE TRIALMichael P. Randall, Weiyun Z. Ai, Bita Fakhri et al.|Hematological Oncology|2025Cited by 0